We are live on ! Find out more
PCH

Polar Capital Holdings Portfolio holdings

AUM $42.4B
1-Year Est. Return 181.11%
This Fund
S&P 500
This Quarter Est. Return
+15.4%
1 Year Est. Return
+181.11%
3 Year Est. Return
+584.8%
5 Year Est. Return
+777.19%
10 Year Est. Return
AUM
$17.9B
AUM Growth
-$3.08B
Cap. Flow
-$132M
Cap. Flow %
-0.74%
Top 10 Hldgs %
31.19%
Holding
330
New
43
Increased
82
Reduced
112
Closed
34

Top Buys

Rank Stock Value
1
GEV icon
GE Vernova
GEV
+$164M
2
MRVL icon
Marvell Technology
MRVL
+$135M
3
GLW icon
Corning
GLW
+$124M
4
CLS icon
Celestica
CLS
+$112M
5
DDOG icon
Datadog
DDOG
+$110M

Sector Composition

Rank Sector Weight
1 Technology 42.96%
2 Financials 17.48%
3 Healthcare 15.13%
4 Communication Services 13.07%
5 Consumer Discretionary 6.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FSLR icon
101
First Solar
FSLR
$22.3B
$43.7M 0.24%
247,749
-426,021
-63% -$84.8M
RLI icon
102
RLI Corp
RLI
$5.55B
$42.9M 0.24%
520,000
BEKE icon
103
KE Holdings
BEKE
$18.4B
$42.6M 0.24%
2,313,217
+567,492
+33% +$11.7M
NTNX icon
104
Nutanix
NTNX
$17.8B
$42.6M 0.24%
695,665
-169,900
-20% -$11.1M
MDGL icon
105
Madrigal Pharmaceuticals
MDGL
$12.3B
$42.5M 0.24%
137,720
+37,245
+37% +$10.5M
BSX icon
106
Boston Scientific
BSX
$62.3B
$42.4M 0.24%
474,680
-71,696
-13% -$6.31M
FAF icon
107
First American
FAF
$7.33B
$42.1M 0.24%
675,000
BRO icon
108
Brown & Brown
BRO
$22.1B
$42.1M 0.24%
412,500
ROIV icon
109
Roivant Sciences
ROIV
$29.5B
$41.4M 0.23%
3,500,000
ASND icon
110
Ascendis Pharma A/S
ASND
$17.3B
$41.3M 0.23%
300,000
+75,000
+33% +$9.86M
REGN icon
111
Regeneron Pharmaceuticals
REGN
$80.5B
$40.1M 0.22%
56,249
-15,546
-22% -$13M
CLDX icon
112
Celldex Therapeutics
CLDX
$2.9B
$39.6M 0.22%
1,565,831
-1,155,046
-42% -$31.4M
IBKR icon
113
Interactive Brokers
IBKR
$41.1B
$39.5M 0.22%
893,632
-36,920
-4% -$1.55M
ABBV icon
114
AbbVie
ABBV
$454B
$39M 0.22%
219,516
-11,955
-5% -$2.2M
IOT icon
115
Samsara
IOT
$25.1B
$38.9M 0.22%
889,429
-31,666
-3% -$1.56M
MMSI icon
116
Merit Medical Systems
MMSI
$5.16B
$37M 0.21%
382,697
-30,068
-7% -$3M
RNAM
117
DELISTED
Avidity Biosciences
RNAM
$37M 0.21%
1,271,891
-270,235
-18% -$11.3M
ITGR icon
118
Integer Holdings
ITGR
$4.28B
$36.1M 0.2%
272,436
-69,311
-20% -$9.24M
ICE icon
119
Intercontinental Exchange
ICE
$88.4B
$36M 0.2%
241,540
-36,941
-13% -$5.85M
ETN icon
120
Eaton
ETN
$165B
$35.6M 0.2%
107,171
-36,480
-25% -$12.8M
FIS icon
121
Fidelity National Information Services
FIS
$19.7B
$35.5M 0.2%
438,960
-15,671
-3% -$1.35M
Z icon
122
Zillow
Z
$7.31B
$33.5M 0.19%
+452,450
New +$32.3M
MCK icon
123
McKesson
MCK
$103B
$33.2M 0.19%
58,285
+6,031
+12% +$3.38M
RVMD icon
124
Revolution Medicines
RVMD
$43.7B
$32.8M 0.18%
+750,665
New +$37.9M
TOST icon
125
Toast
TOST
$18.6B
$31.2M 0.17%
+854,726
New +$30M

Similar funds

Polar Capital Holdings's Q4 2024 Portfolio in Review

As of Q4 2024, Polar Capital Holdings held 330 positions worth $17.9B, down 15% from $21B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Polar Capital Holdings's Q4 2024 filing shows 43 new, 82 increased, 112 reduced and 34 closed positions. Its largest new stake was Corning: 2,614,751 shares worth $124M. The largest sale was Advanced Micro Devices, an estimated $305M.

By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.

  • Polar Capital Holdings's largest Q4 2024 buy was Corning: 2,614,751 shares worth $124M.
  • Polar Capital Holdings added most to GE Vernova in Q4 2024, an estimated $164M increase.
  • Polar Capital Holdings's biggest Q4 2024 reduction was Advanced Micro Devices, cutting an estimated $305M.
  • Polar Capital Holdings fully exited Teradyne in Q4 2024, selling an estimated $130M.
  • Polar Capital Holdings's ten largest holdings make up 31% of its $17.9B portfolio in Q4 2024.
  • Polar Capital Holdings opened 43 new positions and closed 34 in Q4 2024.
  • Polar Capital Holdings's portfolio value fell 15% quarter-over-quarter to $17.9B.

Based on Polar Capital Holdings's 13F filing for Q4 2024, filed 14 Feb 2025.